Artizan Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Artizan Biosciences's estimated annual revenue is currently $1M per year.
- Artizan Biosciences's estimated revenue per employee is $51,000
- Artizan Biosciences's total funding is $26M.
Employee Data
- Artizan Biosciences has 20 Employees.
- Artizan Biosciences grew their employee count by 5% last year.
Artizan Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.8M | 25 | 9% | N/A | N/A |
#2 | $3.1M | 38 | 6% | N/A | N/A |
#3 | $6.2M | 68 | 5% | N/A | N/A |
#4 | $1.7M | 24 | -17% | N/A | N/A |
#5 | $2.5M | 31 | 0% | N/A | N/A |
#6 | $124.7M | 855 | 0% | $29.5M | N/A |
#7 | $4.9M | 53 | 2% | N/A | N/A |
#8 | $3.8M | 46 | 7% | N/A | N/A |
#9 | $0.7M | 12 | N/A | N/A | N/A |
#10 | $6.1M | 66 | 3% | N/A | N/A |
What Is Artizan Biosciences?
Artizan Biosciences, Inc. is a research company leveraging our proprietary IgA-SEQâ„¢ technology platform to distinguish disease-driving bacteria from the intestinal microbiota with the goal of developing new and potentially curative treatments
keywords:N/A
$26M
Total Funding
20
Number of Employees
$1M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Artizan Biosciences News
Artizan Biosciences Announces Issuance of New U.S. Patent to Cover Proprietary Discovery Platform. Published: Mar 29, 2022. NEW HAVEN, Conn., March 29,...
NEW HAVEN, Conn., March 29, 2022 (GLOBE NEWSWIRE) -- Artizan Biosciences, Inc. (Artizan), a biotechnology company creating a new class of...
Agreement enables Biohaven to exercise option on up to three of Artizan’s candidates for the treatment of inflammatory bowel disease Series A-2 led by Hatteras Venture Partners and Biohaven Donnie McGrath, M.D., and Seth Rudnick, M.D., join Artizan’s board of directors NEW HAVEN, Conn., March ...
Other Companies in New Haven
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.1M | 20 | 5% | N/A |
#2 | $3.2M | 20 | -20% | N/A |
#3 | $3M | 21 | 11% | N/A |
#4 | $1.5M | 21 | -12% | $1.8M |
#5 | N/A | 21 | 40% | N/A |